ストックスクリーナーアプリを入手
52.13
0.04%
0.02
アフターアワーズ：
53.00
0.87
+1.67%
Ptc Therapeutics Inc (PTCT) 最新ニュース
What institutional investors are buying PTC Therapeutics Inc. stockAchieve rapid wealth accumulation through smart investing - jammulinksnews.com
Is PTC Therapeutics Inc. a good long term investmentCapitalize on momentum-driven opportunities - jammulinksnews.com
William Blair Lowers Earnings Estimates for PTC Therapeutics - MarketBeat
Should I hold or sell PTC Therapeutics Inc. stock in 2025Get ahead with breakthrough trading ideas - jammulinksnews.com
PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Acquired by XTX Topco Ltd - MarketBeat
What drives PTC Therapeutics Inc. stock priceInvest confidently with professional market insights - jammulinksnews.com
What are the latest earnings results for PTC Therapeutics Inc.Exponentially increasing returns - jammulinksnews.com
How does PTC Therapeutics Inc. compare to its industry peersAchieve breakthrough financial results - jammulinksnews.com
Is it the right time to buy PTC Therapeutics Inc. stockTake advantage of unprecedented market momentum - jammulinksnews.com
What makes PTC Therapeutics Inc. stock price move sharplyIdentify winners with top-tier analysis - jammulinksnews.com
What is the risk reward ratio of investing in PTC Therapeutics Inc. stockInvest with confidence backed by data - jammulinksnews.com
Why is PTC Therapeutics Inc. stock attracting strong analyst attentionExceptional profit velocity - jammulinksnews.com
PTC Therapeutics (NASDAQ:PTCT) Shares Gap Up After Analyst Upgrade - MarketBeat
How does PTC Therapeutics Inc. generate profit in a changing economyBuild a diversified portfolio for risk management - jammulinksnews.com
What are PTC Therapeutics Inc. company’s key revenue driversGet expert insights on market-moving stocks - jammulinksnews.com
Bank of America Forecasts Strong Price Appreciation for PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
Bayforest Capital Ltd Takes $415,000 Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Q3 Earnings Estimate for PTCT Issued By William Blair - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $46.00 at Barclays - MarketBeat
Truist Financial Issues Positive Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price - MarketBeat
PTC Therapeutics (PTCT) to Release Quarterly Earnings on Thursday - MarketBeat
Is PTC Therapeutics Inc. a growth stock or a value stockChart Pattern Tips For Beginners - jammulinksnews.com
Q3 EPS Forecast for PTC Therapeutics Decreased by Analyst - MarketBeat
PTC Therapeutics: Uncertainty Abounds Ahead Of Q2 EarningsI'm Upgrading To 'Hold' - Seeking Alpha
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance
PTC Therapeutics shares rise 1.57% premarket after expanding collaboration with NVIDIA for AI development. - AInvest
Y Intercept Hong Kong Ltd Sells 6,043 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Using data models to predict PTC Therapeutics Inc. stock movementSwing Entry Insight With Forecast Accuracy - Newser
Madrigal buys into GLP-1 from CSPC; Apellis wins expanded drug approval - BioPharma Dive
Wells Fargo & Company Issues Positive Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $120.00 at Cantor Fitzgerald - MarketBeat
PTC Therapeutics (PTCT) Surges 11.2%: Is This an Indication of Further Gains? - Nasdaq
A Quick Look at Today's Ratings for PTC Therapeutics(PTCT.US), With a Forecast Between $46 to $120 - 富途牛牛
Orsini Selected as Specialty Pharmacy Partner for PTC Therapeutics' SEPHIENCE™ (sepiapterin) - Yahoo Finance
36,246 Shares in PTC Therapeutics, Inc. (NASDAQ:PTCT) Purchased by Neo Ivy Capital Management - MarketBeat
Price Reversal in PTC Therapeutics Inc. Traders Watch CloselyBuy Low Sell High Stock Watch Strategy in Focus - beatles.ru
Universal Beteiligungs und Servicegesellschaft mbH Purchases 36,365 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
AI Tools Suggest PTC Therapeutics Inc. May Outperform This WeekSecure Return Focused Investment Plan Released - metal.it
PTC Therapeutics Inc. Breakout Confirmed by Volume MetricsBreakout Momentum Picks With Protection Outlined - metal.it
PTC To Challenge BioMarin In PKU With Oral Sephience - insights.citeline.com
PTC Therapeutics (NASDAQ:PTCT) Shareholders Are Still up 36% Over 1 Year Despite Pulling Back 7.4% in the Past Week - 富途牛牛
PTCT’s Future: A Game Changer? - StocksToTrade
Why Is PTC Therapeutics Stock Trading Higher Today?PTC Therapeutics (NASDAQ:PTCT) - Benzinga
PTC Therapeutics stock price target raised to $120 from $112 at Cantor Fitzgerald - Investing.com
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):